Physician profile
Nancy E Austin
NPI 1588656854
$816.91
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $803 · 2020: $13.92.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $148.44 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $123.59 | 2019 | |
| Allergan, INC. | $79.44 | 2019-2020 | |
| Pfizer INC. | $70.27 | 2019 | |
| Abbott Laboratories | $56.38 | 2019 | |
| Astellas Pharma US INC | $55.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $44.34 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.58 | 2019 | |
| Novo Nordisk INC | $39.32 | 2019 | |
| Scilex Pharmaceuticals INC. | $34.60 | 2019 | |
| Therapeuticsmd, INC. | $34.33 | 2019 | |
| Shire North American Group INC | $24.59 | 2019 | |
| Lilly USA, LLC | $18.29 | 2019 | |
| Merck Sharp & Dohme LLC | $16.88 | 2019 | |
| Daiichi Sankyo INC. | $14.22 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.